Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Sinder Technology is a prominent Chinese biotechnology company dedicated to the animal health sector, specializing in the research, development, and production of veterinary vaccines and pharmaceuticals. The company provides a wide range of products for poultry, swine, and ruminants, focusing on the prevention and control of major infectious diseases such as Avian Influenza and Porcine Reproductive and Respiratory Syndrome (PRRS). Sinder utilizes advanced technological platforms, including reverse genetics and high-density cell suspension culture, to ensure high-quality and effective biological products. With multiple GMP-certified manufacturing sites and a strong R&D network across China, the company serves as a key player in the global animal health industry. Their commitment to innovation is reflected in their numerous patents and collaborations with leading academic and research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Sinder Technology.